Biotech Tests Pig-to-Human Transplants With New Funds

(Bloomberg) -- EGenesis, a biotech company working to alleviate the shortage of organs available for transplants, raised $100 million in new funding for its program that genetically edits organs fr...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.